August 20, 2014

Thanks in part to the launch of Alka-Seltzer Fruit Chews in May of last year, the Alka-Seltzer brand has experienced a resurgence within the antacid tablet category.

August 20, 2014

In May 2014, Pfizer introduced Nexium 24HR, one of the top-selling acid blockers, over the counter in the United States.

August 20, 2014

Pfizer successfully switched Nexium to over-the-counter in late May, and with that brought a $6 billion book of prescription business to antacid aisles, according to IMS Health data compiled over 2012.

August 14, 2014

Tummy Co. recently launched a fast-acting liquid antacid in a shot format called Relief OTC, the company announced Wednesday.

April 3, 2014

First Aid Shot Therapy on Wednesday announced the launch of First Aid Shot Therapy Upset Stomach.

January 10, 2014

Fewer than half of people who could benefit from the heart-health benefits of a daily low-dose aspirin take it, while many others take it when they shouldn't, the January 2014 Harvard Heart Letter reported Friday.

December 26, 2013

Thanks in part to the launch of Alka-Seltzer Fruit Chews, the Alka-Seltzer brand has experienced a resurgence within the antacid tablet category.

December 26, 2013

Heading into 2014, there are a number of growth drivers across the digestives space.

November 13, 2013

Sohm on Tuesday announced the U.S. launch of its umbrella brand SohMed, positioning the company in the generic over-the-counter medicines segment for indications of pain, fever, cold, antacid and alertness.

September 10, 2013

What a difference a year will make. While sales of antacid tablets were down 1.3% to $2 billion for the 52 weeks ended July 14 across total U.S. multi-outlets, according to IRI, the entire category ought to have made a significant resurgence by this time next year.

May 30, 2013

There can't be too many tried-and-true, immediate-action calcium carbonate formulations among heartburn remedies, no matter how many proton-pump inhibitors dot that shelf's landscape. At least that's what Bayer Consumer is counting on with its line extension of Alka Seltzer Fruit Chews.

May 30, 2013

It was only a matter of time before a Hispanic-centric OTC product with roots in South America started making its way toward the top of consumer packaged goods sales lists. Bristol-Myers Squibb de Mexico's Sal de Uvas Picot is the third-largest liquid/powder antacid brand on the market today for the 12 weeks ended April 21.

August 17, 2012

Procter & Gamble’s Prilosec OTC still is the best-selling antacid on the market, with more than $252.7 million in annual sales for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), followed by fellow proton-pump inhibitor Novartis’ Prevacid 24HR ($104.1 million).


February 9, 2012

The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.

December 2, 2011

Axia3 on Thursday announced the launch of its Axia3 ProDigestive antacid as a new dietary supplement that delivers relief from occasional heartburn, with a proprietary blend of potent ProDigestive enzymes to help promote healthy digestion.

October 11, 2011

Sales of antacid tablets are up almost 3%. And while nobody is suggesting that upward trajectory is going to change anytime soon, there will be a decent amount of volatility in the coming year.


July 25, 2011

Sales in the digestives aisle going forward look positive, especially as an aging population begins paying closer attention to healthy diets, including the right amount of dietary fiber to keep things “regular” and supplementation with probiotics for overall digestive health. 


March 4, 2011

NEW YORK — Sure, the plethora of proton-pump inhibitors dotting digestive aisles these days have generated plenty of buzz among antacids, but what do heartburn sufferers do while they wait for the PPI to begin working? They turn to an immediate relief option like the Tums and Tums Ultra brands, which together generated growth of 96.3% to $24.9 million for the 12 weeks ended Jan. 23 across food, drug and mass (minus Walmart), according to SymphonyIRI Group data.

December 7, 2010

NEW YORK — Last year, the big question on every­one’s mind was: How many brands can actually thrive in what has become a cluttered antacid shelf? Because just exactly how many heartburn sufferers are there?


February 17, 2010

Choosing the wrong liquid Maalox product can have harmful consequences, the Food and Drug Administration...